EPIRUS Biopharmaceuticals, Inc.

CIK 1135906 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for EPIRUS Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
May 14, 2024REVOKED9999999997-24-002666
Feb 14, 2017SC 13G/A0001654954-17-001048
Sep 26, 201625-NSE0001354457-16-000508
Aug 1, 20168-K0001104659-16-135667
Jul 25, 20168-K0001104659-16-134031
Jul 11, 2016SC 13G/A0001137774-16-000252
Jul 11, 2016SC 13G/A0000315066-16-006007
Jul 8, 2016SC 13G/A0000053417-16-000384
Jul 1, 20168-K0001104659-16-130852
Jun 14, 20168-K0001104659-16-127110
May 31, 201640001104659-16-124527
May 31, 201640001104659-16-124523
May 31, 201640001104659-16-124526
May 31, 201640001104659-16-124524
May 10, 201610-Q0001558370-16-005832
May 9, 20168-K0001104659-16-119230
Apr 29, 201610-K/A0001104659-16-115567
Mar 29, 2016S-80001104659-16-108284
Mar 29, 201610-K0001558370-16-004428
Mar 15, 20168-K0001104659-16-105050
Mar 15, 2016NT 10-K0001104659-16-105231
Mar 11, 20164/A0001104659-16-104508
Feb 12, 2016SC 13G/A0000919574-16-010152
Feb 12, 2016SC 13G/A0001546927-16-000386
Feb 9, 20168-K0001104659-16-094821